AstraZeneca reported $10.98B in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Alcon AG ALC:SW USD 2.14B 77M
Amgen AMGN:US USD 6.84B 187M
Artemis Alpha ATS:LN GBP -25863000 16.53M
AstraZeneca AZN:LN USD 10.98B 211M
AstraZeneca AZN:SS USD 10.98B 211M
Astrazeneca AZN:US USD 10.98B 211M
Bayer BAYN:GR EUR 11.28B 1.54B
Biogen BIIB:US USD 2.51B 80.6M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Eli Lilly And LLY:US USD 7.3B 360.2M
Fresenius FRE:GR EUR 10.46B 441M
Fresenius Medical Care FME:GR EUR 5.1B 339.17M
Galapagos GLPG:NA EUR 148.04M 473K
Genmab GEN:DC DKK 4.09B 925M
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Merck MRK:GR EUR 5.81B 238M
Merk MRK:US USD 13.83B 1.13B
Novartis NOVN:VX USD 13B 159M
Orion ORNBV:FH EUR 491.8M 208.1M
Pfizer PFE:US USD 24.29B 1.65B
Philips PHIA:NA EUR 5.42B 1.11B
Recordati REC:IM EUR 485.05M 11.94M
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Roche Holding ROG:VX CHF 32.3B 207M